GlassScriptPhysician profile
Srinivasa K Gorjala
NPI 1639167299
$137,571.31
in general payments reported to CMS, 2019-2025
35 companies · $28K in 2025
The $28K reported for 2025 was more than what 98% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,811 · 2020: $1,819 · 2021: $3,714 · 2022: $27K · 2023: $41K · 2024: $30K · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $72K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $6,719 · Travel and Lodging: $6,601 · Education: $1,000 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $72,312.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,562.50 |
| Food and Beverage | $6,718.73 |
| Travel and Lodging | $6,600.90 |
| Education | $1,000.00 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $98,289.19 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Teleflex LLC | $14,630.22 | 2019-2025 | Titan Sgs Bailout Chuck, Titan Sgs |
| Intuitive Surgical, INC. | $14,080.02 | 2019-2025 | Da Vinci Surgical System |
| Medtronic, INC. | $2,910.53 | 2019-2025 | Endoflip, Stealthstation S8 Platform, Bravo |
| Endolumik, INC. | $2,000.00 | 2025 | Endolumik Gastric Calibration Tube |
| Baxter Healthcare | $1,407.58 | 2019-2024 | Peri-Strips Dry, Tisseel |
| Medical Device Business Services, INC. | $776.81 | 2019 | |
| Covidien LP | $550.12 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $516.64 | 2019-2021 | |
| Novo Nordisk INC | $287.28 | 2023-2025 | Wegovy |
| Ethicon US, LLC | $259.21 | 2020-2024 | Linx Reflux Management System, Linx Reflux Management System |
| Reshape Lifesciences INC. | $240.99 | 2019-2022 | |
| Pinnacle Biologics, INC | $237.78 | 2024 | Photofrin |
| Coloplast Corp | $194.70 | 2023-2025 | Titan |
| W. L. Gore & Associates, INC. | $161.28 | 2020-2023 | Seamguard |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $150.00 | 2019 | |
| Allergan, INC. | $148.36 | 2022 | |
| Intra-Sana Laboratories | $126.83 | 2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Ambu INC. | $104.52 | 2020-2022 | |
| Conmed Corporation | $97.71 | 2020-2024 | Airseal |
| Apollo Endosurgery US INC | $78.56 | 2019 | |
| Integra Lifesciences Corporation | $47.31 | 2020-2023 | Integra, Surgimend, Omnigraft |
| Daiichi Sankyo INC. | $34.22 | 2022 | |
| Endogastric Solutions, INC | $31.76 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $24.44 | 2025 | |
| Dexcom, INC. | $23.88 | 2025 | Dexcom G6 Transmitter |
| Redhill Biopharma INC. | $22.83 | 2020-2021 | |
| Stryker Corporation | $22.19 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.57 | 2021 | |
| Heron Therapeutics, INC. | $18.23 | 2023 | Zynrelef |
| Reprise Biomedical, INC. | $18.18 | 2022 | |
| Davol INC. | $16.33 | 2019 | |
| Lilly USA, LLC | $16.26 | 2025 | Zepbound |
| Currax Pharmaceuticals LLC | $14.12 | 2024 | Contrave |
| Mimedx Group, INC. | $13.66 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Srinivasa Gorjala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.